Probiotics and gastrointestinal disease: successes, problems and future prospects.
about
The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cellsGut Microbiota and Hepatocellular CarcinomaDesigner probiotics: Development and applications in gastrointestinal healthAnhydrobiosis in bacteria: from physiology to applicationsAdvances in the Microbiome: Applications to Clostridium difficile InfectionProbiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.Short- and long-term biomarkers for bacterial robustness: a framework for quantifying correlations between cellular indicators and adaptive behavior.Relationship between oral malodor and the global composition of indigenous bacterial populations in saliva.Effect of a multi-species synbiotic formulation on fecal bacterial microbiota of healthy cats and dogs as evaluated by pyrosequencing.Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro.Functional metagenomics reveals novel salt tolerance loci from the human gut microbiomeCompatible solutes: the key to Listeria's success as a versatile gastrointestinal pathogen?Compatible solutes: A listerial passe-partout?Functional environmental screening of a metagenomic library identifies stlA; a unique salt tolerance locus from the human gut microbiome.Metagenomic biomarker discovery and explanation.Under the microscope: From pathogens to probiotics and back.Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenomeThe Role of the Microbiome and the use Of Probiotics in Gastrointestinal Disorders in Adults in the Asia-Pacific Region.Probiotics for human health -new innovations and emerging trends.Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencingMicrobial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC).Bioengineered probiotics, a strategic approach to control enteric infectionsMetagenomics and novel gene discovery: promise and potential for novel therapeutics.Mining the human gut microbiome for novel stress resistance genes.Probiotic as a novel treatment strategy against liver diseaseExploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance.Probiotic therapy - recruiting old friends to fight new foesUnderstanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence?Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome.Probiotic Escherichia coli CFR 16 producing pyrroloquinoline quinone (PQQ) ameliorates 1,2-dimethylhydrazine-induced oxidative damage in colon and liver of rats.Molecules produced by probiotics prevent enteric colibacillosis in pigs.Probiotic, Prebiotic, and Brain Development.The human gut microbiome: the ghost in the machine.Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp.Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer
P2860
Q24633800-76461E40-BCFB-4582-BA57-462987DA1963Q26775568-E2D77E12-D05F-4371-AEE9-A81714233504Q26795388-A0E928A9-6D9A-428E-8411-628C818F3620Q26828798-DDB1AD90-39EC-46FA-AD81-C04C28837EAAQ28066362-32DEF820-16FF-4105-A17B-ACE3BF922F89Q33651733-E87133D9-B90D-4199-9CDD-965F17A59091Q33741862-396D82A0-FC15-4A2D-A18E-7E46874158FAQ33825820-D5477688-52A8-464F-8A6E-5FEFD733A9B4Q34069944-1465FEF4-4B0C-4C85-8381-522867BEB46BQ34123613-9E658795-8AA3-4FA8-BB5C-27930ADCC974Q34245960-88876811-F10F-411D-8EC9-240467A65779Q34426565-CAFA6122-CEF0-4E22-803C-2F1BE178B450Q34503552-9F02A77E-705C-4CD4-BA63-EB4325A33575Q35070691-40FE4624-E7EF-4B50-AEA7-34C757FB6FCCQ35557728-42107EF5-40E1-46ED-99FA-DC4EA319924FQ35764530-B475AB68-1890-4F77-A1F6-5BA4525B7ACCQ35896703-4F864034-B981-46AE-965E-6068FA9C8C97Q36394638-496232F2-BC62-4846-A5A1-8A3B2FBF87BFQ36531370-B0A43946-1D40-4690-9BA4-C8BB1C1C67E7Q36939976-EE0BE972-B1B3-42BB-8005-1F208923BC1EQ37542178-03E8ECD5-6F77-48C1-BD78-A066058A42FBQ37607761-C00866B2-F2F0-48D3-AE38-A2EBED9A6FCAQ37692518-7B5B5CCF-0908-448D-B7A5-EE04ECB22ED1Q39604581-A8143FE3-FD87-4A6C-8F28-F444E7398652Q39974040-07EEFF6F-64F6-4A79-AD5D-69814D9D6F18Q40185364-5724C4C2-B7A1-4294-BA6A-846F4F7895A5Q42652018-26D32D6C-EEEA-4EAF-8638-67D15BC3CF0FQ42657761-ADFB73CA-C295-4686-923F-68EEAD1617CAQ43097131-931ABB72-2B9E-4C81-9741-C5711E2A17EDQ46907571-A57EEE25-0140-4658-9928-A248A47A4873Q46950723-C333A5A1-5A2D-4042-82FC-F929CDCA3D1AQ47114796-FF58DE80-ADCE-4973-BA0B-567544665146Q47278589-98ADCCA6-6F8D-4576-9859-2CE130EFC8C8Q53685610-4959169C-9C6E-4F66-89E4-03512E546C42Q58777471-FAA2797E-5DEC-465B-8E04-E61FCEA0C00A
P2860
Probiotics and gastrointestinal disease: successes, problems and future prospects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Probiotics and gastrointestinal disease: successes, problems and future prospects.
@en
Probiotics and gastrointestinal disease: successes, problems and future prospects.
@nl
type
label
Probiotics and gastrointestinal disease: successes, problems and future prospects.
@en
Probiotics and gastrointestinal disease: successes, problems and future prospects.
@nl
prefLabel
Probiotics and gastrointestinal disease: successes, problems and future prospects.
@en
Probiotics and gastrointestinal disease: successes, problems and future prospects.
@nl
P2093
P2860
P356
P1433
P1476
Probiotics and gastrointestinal disease: successes, problems and future prospects.
@en
P2093
Colin Hill
Eamonn P Culligan
Roy D Sleator
P2860
P2888
P356
10.1186/1757-4749-1-19
P577
2009-11-23T00:00:00Z
P5875
P6179
1017423113